Target intelligence / Profile preview

Wings apart-like protein homolog (WAPL)

Target
WAPL
Molecular classification
Other (Chromosome cohesion regulator), Chromatin-associated protein, HEAT repeat protein
01

Overview

Wings apart-like protein homolog (WAPL) is a highly conserved eukaryotic protein that regulates chromosome architecture by controlling the dynamic association of the cohesin complex with chromatin through the cell cycle[1][2][3]. WAPL forms complexes with Pds5 to mediate the release of cohesin rings from chromatin, enabling chromosome segregation during mitosis and contributing to higher-order chromatin organization[1][2][3][5]. The protein features a flexible N-terminal domain and a conserved C-terminal domain composed of HEAT repeats, and it binds cohesin using specific recognition motifs[1][3][4]. Disruption of WAPL activity leads to chromosome segregation errors, highlighting its importance in genomic stability; however, WAPL itself is not a direct therapeutic target, and no drugs selectively modulate its activity as of current knowledge[2][5]. Key insights: - WAPL acts as a critical negative regulator of cohesin, controlling the timing of sister chromatid separation by releasing cohesin from chromosomes prior to anaphase[1][2][5]. - Mutations or experimental depletion of WAPL cause defects in chromosome segregation and lead to genomic instability[2][5]. - While WAPL is crucial for cell division fidelity, its direct pharmacological targeting is not established; rather, research focuses on cohesin pathway modulation for cancer and other disease states[2][4].

Other names
WAPLWAPALFOEKIAA0261Friend of EBNA2 proteinwings apart-like protein homologfriend of EBNA2 (Epstein-Barr virus nuclear antigen 2)WAPL cohesin release factor
02

Mechanism of action

Not applicable (no drugs currently target WAPL directly; mechanistically, WAPL triggers opening of cohesin ring and release from DNA by interacting with specific cohesin subunits)

03

Biological functions

Sister chromatid cohesion regulationCohesin release from chromatinChromosome segregationChromatin architecture and 3D genome organization
04

Disease associations

Cancer (chromosome segregation errors due to WAPL dysregulation may contribute to genomic instability in cancer)Other (genomic instability, cell division defects)
05

Safety considerations

Not applicable for drug targeting WAPL directly; theoretically, interfering with WAPL function may cause chromosome missegregation, aneuploidy, and toxicity due to impaired cell division

Beyond the preview

Go deeper on Wings apart-like protein homolog (WAPL).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Wings apart-like protein homolog (WAPL).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call